Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria B. L. Leys
Observed names:
M Leys,
Maria B.L. Leys,
Maria BL Leys
Institution:
Maasstad Ziekenhuis
Observed institutions:
University of Cologne,
Maasstad Ziekenhuis,
Essen University Hospital,
Erasmus MC Cancer Institute,
University Hospital Cologne,
University of Duisburg-Essen
show all 6
ORCID:
0000-0002-2862-1349
Observed ORCID:
0000-0002-2862-1349
OpenAlex ID:
A5064117166
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
2023
·
Barbara Eichhorst
, Carsten U. Niemann
, et al.
·
New England Journal of Medicine
·
305
Effects of Implementation of a Standardized Palliative Care Pathway for Patients with Advanced Cancer in a Hospital: A Prospective Pre- and Postintervention Study
2021
·
Annemieke van der Padt-Pruijsten
, Maria B.L. Leys
, et al.
·
Journal of Pain and Symptom Management
·
13
PDF
Hospitalisations of patients with cancer in the last stage of life. Reason to improve advance care planning?
2022
·
Annemieke van der Padt‐Pruijsten
, Tanja Oostergo
, et al.
·
European Journal of Cancer Care
·
10
PDF
Quality of hospital discharge letters for patients at the end of life: A retrospective medical record review
2021
·
Marijanne Engel
, Annemieke Padt‐Pruijsten
, et al.
·
European Journal of Cancer Care
·
7
PDF
Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
2023
·
Kazimierz Groen
, Fredrik H. Schjesvold
, et al.
·
HemaSphere
·
2
The effect of a palliative care pathway on medical interventions at the end of life: a pre-post-implementation study
2022
·
Annemieke van der Padt-Pruijsten
, Maria B. L. Leys
, et al.
·
Supportive Care in Cancer
·
2
PDF
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study
2026
·
Marie José Kersten
, Martin Dreyling
, et al.
·
Haematologica
Quality of cancer treatment care before and after a palliative care pathway: bereaved relatives’ perspectives
2023
·
Annemieke van der Padt - Pruijsten
, Maria BL Leys
, et al.
·
BMJ Supportive & Palliative Care
PDF
A pre-post intervention study on the effects of implementation of a Palliative Care Pathway for patients with advanced cancer: less medical interventions during the last three months of life
2022
·
Annemieke van der Padt - Pruijsten
, Maria B.L. Leys
, et al.
·
Research Square
PDF
OP14 Effects of implementation of a standardised palliative care pathway for patients with advanced cancer in a dutch hospital
2019
·
A Van der Padt - Pruijsten
, M Leys
, et al.
·
Oral Presentations
PDF
Show more works
View as search
Works count:
10
Citation count:
339
H-index:
4
I10-index:
3
Year
Topic
Type